MELBOURNE, Australia and INDIANAPOLIS, Ind., April 14, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) (“Telix”) today launches an offering of US$550 million convertible…
LIVE
--
--
--
--
--
--
--
--
Official App
Download world's #1 News App
Get real-time alerts on your phone
